TrialBreast cancer research : BCR2023

The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.

Pauline Wimberger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.